Hims & Hers Health Stock: A Comprehensive Analysis
Recently, Diversify Advisory Services LLC decreased its stake in Hims & Hers Health, Inc. (NYSE:HIMS) by 62.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). This move has sparked interest in the company’s stock performance and future prospects.
Hims & Hers Health Stock Performance
Hims & Hers Health, Inc. has a 52-week low of $13.74 and a 52-week high of $70.43. The firm’s 50-day moving average is $24.18, and its 200-day moving average is $37.66. The company has a market capitalization of $5.90 billion, a P/E ratio of 50.76, a P/E/G ratio of 4.55, and a beta of 2.55.
Quarterly Earnings Data
Hims & Hers Health last issued its quarterly earnings data on Monday, February 23rd. The company reported $0.08 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.06. The business had revenue of $617.82 million during the quarter, compared to the consensus estimate of $619.48 million.
Wall Street Analysts’ Forecast
A number of brokerages have commented on HIMS. BTIG Research downgraded shares of Hims & Hers Health from a “buy” rating to a “neutral” rating. TD Cowen decreased their price objective on shares of Hims & Hers Health from $20.00 to $17.00 and set a “hold” rating for the company.
Insider Transactions
In related news, CFO Oluyemi Okupe sold 9,067 shares of the business’s stock in a transaction on Tuesday, January 20th. The shares were sold at an average price of $30.34, for a total value of $275,092.78.
Conclusion and Future Prospects
In conclusion, Hims & Hers Health, Inc. has shown promising growth and revenue increase. However, the company’s stock performance has been affected by various factors, including institutional selling and analyst downgrades. Meanwhile, the company’s partnership with Novo Nordisk and its expansion into new markets are expected to drive future growth.
For example, the company’s partnership with Novo Nordisk has been seen as a transformational deal for revenue and margins. Additionally, the company’s strong 2025 operating results provide context for its future prospects.
Therefore, investors should keep a close eye on the company’s future developments and announcements. Furthermore, it is essential to consider the company’s financials, management team, and industry trends when making investment decisions.
FAQs
Here are some frequently asked questions about Hims & Hers Health, Inc.:
- What is Hims & Hers Health, Inc.’s stock symbol? The company’s stock symbol is NYSE:HIMS.
- What is the company’s market capitalization? The company has a market capitalization of $5.90 billion.
- What is the company’s P/E ratio? The company has a P/E ratio of 50.76.
- What is the company’s future growth prospect? The company’s partnership with Novo Nordisk and its expansion into new markets are expected to drive future growth.
- What is the company’s focus keyword? The company’s focus keyword is Hims & Hers Health stock.
